RxDoctor Payments Data

Laura Hill

Adult Health · O Fallon, MONPI 1194923151

Payments from drug & device makers

$256in general payments, 2019–2025

Across 16 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$80
  • AbbVie$41
  • Biohaven Pharmaceutical Holding Company Ltd.$36
  • Valinor Pharma, LLC$16
  • Amgen$15
  • Bayer$15
  • plus $52 from 4 others

What the payments were for

  • Food & beverage$256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK5$80
AbbVie2$41
Biohaven Pharmaceutical Holding Company Ltd.2$36
Valinor Pharma, LLC1$16
Amgen1$15
Bayer1$15
Pfizer1$14
Novo Nordisk1$14
Boehringer Ingelheim1$13
Johnson & Johnson1$11

How this compares

$256 in reported general payments places this provider in the 35th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri

Medicare billing

Part B allowed, 2024
$30,649
Medicare patients
199
Services billed
419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$11,709
XareltoRivaroxaban11$9,430
Albuterol Sulfate HfaAlbuterol Sulfate31$539
Fluticasone Propionate27$518
Methylprednisolone76$474
Mirtazapine21$444
Omeprazole19$419
Cefdinir21$371
Levothyroxine Sodium33$337
Duloxetine Hcl15$307
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$264
Metoprolol Succinate16$245
Diclofenac Sodium32$236
Rosuvastatin Calcium31$212
Losartan Potassium23$202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$11,70921 claims
Johnson & JohnsonXarelto$11$9,43011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 555 adult health providers in Missouri.

Other adult health in O Fallon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →